Oct 29
Earnings call
Q2 2027 earnings call
Sudeep Pharma reported Q2 FY27 revenue of INR196.7 crores and EBITDA of INR73.2 crores, up 21% and 32% year-on-year. Pharma Food Nutrition revenue grew 57%, while the Dahej battery-materials project remains targeted to begin operations in April 2027.